scholarly journals Comparative Analysis between Real Cost and INA-CBG’s claims of Service Costs in Chronic Kidney Disease Patients with Hemodialysis

2020 ◽  
Vol 9 (2) ◽  
pp. 726-732
Author(s):  
Riqqah Nadhira ◽  
Irwan Saputra ◽  
Said Usman ◽  
Bakhtiar Bakhtiar ◽  
Nurjannah Nurjannah
Keyword(s):  
Unit Cost ◽  
Secondary Data ◽  
Cost Of Care ◽  
P Value ◽  
Cost Difference ◽  
Real Cost ◽  
Hemodialysis Unit ◽  
Study Population ◽  
The Cost ◽  
Real Costs

This study was an observational analytic study conducted in the Hemodialysis unit of Zainal Abidin Hospital (RSUDZA), Banda Aceh, Indonesia. Data collection was carried out by taking secondary data from CKD patient visits in January-December 2019. The study population was all CKD patients in the registry of 2019 in the hospital, with a total of 406 patients enrolled. The highest unit cost of care based on real costs was the cost of surgical procedures, and the cost difference between INA-CBG’s and hospital tariffs in the treatment of patients with CKD is significantly different (p-value = 0.014, with gap difference of IDR 2,146,086). It is suggested  an urgent evaluation and scrutinization for the management of CKD patients with hemodialysis to prevent the different treatment costs in the service

Discussion

2010 ◽  
pp. 346-351
Author(s):  
Patricia Cerrito ◽  
John Cerrito
Keyword(s):  
Clinical Trials ◽  
Linear Regression ◽  
Large Datasets ◽  
Cost Of Care ◽  
P Value ◽  
Confounding Factors ◽  
Chi Square ◽  
Sequential Treatments ◽  
The Cost ◽  
Improve Patient

Now that the data are more readily available for outcomes research and the techniques to analyze that data are available, we need to use the tools to investigate the total complexity of patient care. We should no longer rely upon basic tools while ignoring sequential treatments for patients with chronic diseases or the issue of patient compliance, and we can start investigating treatments from birth to death. It is no longer possible, with these large datasets, to rely on t-tests, chi-square statistics and simple linear regression. Without the luxury of clinical trials and randomizing patients into treatment versus control, there will always be confounding factors that should be considered in the data. In addition, large datasets almost guarantee that the p-value in a standard regression is statistically significant, so other methods of model adequacy must be used. If we do not start using outcomes data, we are missing crucial knowledge that can be used to improve patient outcomes while simultaneously reducing the cost of care. If we continue to use inferential statistical methods that were not designed to work with large datasets, we will not extract the information that is readily available in the outcomes datasets.

scholarly journals Costs of reusable and disposable aprons in a public teaching hospital

2014 ◽  
Vol 48 (5) ◽  
pp. 915-921
Author(s):  
Paloma de Souza Cavalcante Pissinati ◽  
Maria do Carmo Lourenço Haddad ◽  
Mariana Ângela Rossaneis ◽  
Roseli Broggi Gil ◽  
Renata Aparecida Belei
Keyword(s):  
Direct Cost ◽  
Teaching Hospital ◽  
Average Cost ◽  
Secondary Data ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Cross Sectional ◽  
Hospital Managers ◽  
Study Population ◽  
The Cost

Objective To analyze the direct cost of reusable and disposable aprons in a public teaching hospital. Method Cross-sectional study of quantitative approach, focusing on the direct cost of reusable and disposable aprons at a teaching hospital in northern Paraná. The study population consisted of secondary data collected in reports of the cost of services, laundry, materials and supplies division of the institution for the year 2012 Results We identified a lower average cost of using disposable apron when compared to the reusable apron. The direct cost of reusable apron was R$ 3.06, and the steps of preparation and washing were mainly responsible for the high cost, and disposable apron cost was R$ 0.94. Conclusion The results presented are important for hospital managers properly allocate resources and manage costs in hospitals
.

scholarly journals PERBANDINGAN ESTIMASI ANGGARAN BIAYA ANTARA PEMERINTAH KABUPATEN BLITAR DENGAN PEMERINTAH KOTA BLITAR PADA PEMBANGUNAN JALAN TEMBUS DI JL. KURMA KOTA BLITAR

2017 ◽  
Vol 7 (1) ◽  
pp. 1-10
Author(s):  
Nandang Prasetiyo
Keyword(s):  
Secondary Data ◽  
Road Construction ◽  
Scientific Work ◽  
Cost Difference ◽  
Work Time ◽  
Access Road ◽  
The Government ◽  
The Cost ◽  
Research Budget

The scientific work entilited Comparison of the estimated budget between the government kabupaten blitar with government blitar city on construction of access road in Jl. Kurma blitar City aims to knowing the cost of building a road through on jl. Kurma knowing the cost of building a road through on jl. Kurma to know the different costs of road construction budged breaks on jl.kurma with an estimated price of materials and wages of two distinct regionsThe study estimates the cost of the budget implemented in CV. EKA CONSULTANT with methods of primary and secondary data collectionOf the research budget estimates resulting cost difference significant budget lies in masonry work time

scholarly journals Nexus of bank personnel and cost-income ratio (CIR) in Nigeria

2017 ◽  
Vol 12 (4) ◽  
pp. 154-162
Author(s):  
Odunayo Magret Olarewaju ◽  
Olusola Olawale Olarewaju ◽  
Titilayo Moromoke Oladejo ◽  
Stephen Oseko Migiro
Keyword(s):  
Causal Relationship ◽  
Unit Root ◽  
Banking Sector ◽  
Unit Cost ◽  
Unit Root Test ◽  
Secondary Data ◽  
Long Run ◽  
Income Ratio ◽  
The Stability ◽  
The Cost

This study investigates the causal relationship between bank personnel ratio and the cost-income ratio based on performance in Nigeria for the period of 2004–2015. Secondary data collected on a cross section of 15 banks during this period was analyzed using panel unit root, cointegration and Granger causality techniques. A unit root test revealed that the variables are stationary at order one. The result further shows there is an equilibrium relationship or stability in the short and long run; furthermore, there is a bidirectional causal relationship between personnel ratio and cost-income ratio. Therefore, the study recommends that the apex bank should enforce policies in the banking sector that will minimize the unit cost of operation – even though they might hire more staff. This is to enhance the stability of the banks in Nigeria and to avoid any threat to their continuity.

scholarly journals Comparison of Real Costs against the Price of INA-CBG's Ischemic Stroke in Bethesda Hospital

2017 ◽  
Vol 7 (2) ◽  
pp. 105 ◽  
Author(s):  
Muslimah Muslimah ◽  
Tri Murti Andayani ◽  
Rizaldy Pinzon ◽  
Dwi Endarti
Keyword(s):  
Ischemic Stroke ◽  
Secondary Data ◽  
Cross Sectional ◽  
Outpatient Visits ◽  
Rs Analysis ◽  
The Subject ◽  
Cross Sectional Design ◽  
The Cost ◽  
Real Costs ◽  
Observation Period

Stroke is the leading cause of death and disability that includes disability mild, moderate and severe need of maintenance costs high. The purpose of this research is to know the characteristics of the patient, the comparison of real costs and fares INA CBG's ischemic stroke inpatient and outpatient in Bethesda HOSPITAL Yogyakarta. This research was conducted with observational analytic approach with cross sectional design based on the perspective of the hospital. The subject of research that meets the criteria of inclusion as much as 96 patients. Criteria for Inclusion include patient JKN, ischemic stroke of the first offensive, onset of less than 24 hours and non of the references. Observation period 1 October 2015 sd 31 March 2016 inpatients were observed 6 months in retrospective. Secondary data research data are sourced on the medical record, IFRS, and Technology Unit of RS. Analysis of statistical data by the method of Mann Whitney and Kruskal Wallis. Based on the characteristics of long hospitalizations, inpatient class there is significant influence (p < 0.05) against ischemic stroke patients real costs of hospitalization. The total real costs RS ischemic stroke of Rp 993,181,170 to 96 111 patients with inpatient visits so that the cost of Rp 8,947,578 per episode of hospitalization. Furthermore the Total cost of stroke ischemic amounting to Rp 139,165,150 with 211 outpatient visits so that the cost of Rp 659,550 per an outpatient episode. Real costs RS ischemic stroke than outpatient rates INA CBG's-2014 have significant differences. Similarly the real costs of hospitalization compared to price of INA-CBG's 2014 have significant differences in class i. In conclusion Fund fares INA-CBG's either outpatient or inpatient insufficient finance the care of patients ischemic stroke in Bethesda hospital Yogyakarta.

scholarly journals Cost of Treatment Demam Berdarah Dengue (DBD) di Rawat Inap Berdasarkan Clinical Pathway di RS X Jakarta

2017 ◽  
Vol 2 (2) ◽  
Author(s):  
Vera Marietha Meinar Rejeki ◽  
Atik Nurwahyuni
Keyword(s):  
Health Care Providers ◽  
Clinical Pathway ◽  
Clinical Pathways ◽  
Unit Cost ◽  
Care Providers ◽  
Cost Of Treatment ◽  
Cross Sectional ◽  
Dengue Disease ◽  
Real Cost ◽  
The Cost

Abstrak Rumah Sakit sebagai pemberi layanan kesehatan saat ini dituntut untuk melakukan kendali mutu dan biaya, namun tetap berkualitas. Clinical pathway yang menjadi dasar pengendalian mutu dan biaya sudah ada tetapi belum diaudit penggunaan­nya oleh tim rumah sakit. Penelitian ini bertujuan untuk mengetahui unit cost layanan dan cost of treatment DBD di RS X Ja­karta. Penelitian kuantitatif melalui pengambilan data cross sectional dengan jumlah sampel penelitian sebanyak 190 pasien DBD. Hasil penelitian didapatkan adanya kesenjangan antara cost of treatment perawatan pasien DBD berdasarkan clinical pathway (Rp. 2.184.588) dan cost of treatment berdasarkan kondisi riil (Rp. 2.382.512) dengan selisih terbesar di rawat inap dan obat-obatan. Cost of treatment tanpa perhitungan gaji dan investasi untuk pasien DBD dapat berkurang menjadi 29% dari cost of treatment semula. Cost of Treatment tanpa perhitungan gaji maka cost of treatment dapat turun menjadi 42%. Diperlukan sistem pemantauan kepatuhan terhadap clinical pathway, pembentukan tim casemix rumah sakit untuk peman­tauan dan evaluasi implementasi JKN di rumah sakit .Abstract Hospitals as health care providers are now required to perform cost and quality control without neglecting the quality of services. Clinical pathways which underlying quality and cost control in the hospital are available but has not been audited. This study aims to determine the unit cost of services in RS X Jakarta, the utilization of hospital services for dengue disease and cost of treatment of DHF in RS X Jakarta. A cross-sectional study was performed in this study. A quantitative approach was done through data collection from hospital information system, medical record and financial data. The result showed that there was a gap between the cost of treat­ment of DHF patients which based on the clinical pathway (2,184,588 IDR) and the cost of treatment based on the real condition (2,382,512 IDR). The biggest difference between cost of treatment and real cost was in the hospitalization cost and medicine cost. Cost of treatment without salary and investation calculation for DHF patients can be reduced significantly by 29%. Cost of treatment without salary calculation for DHF patients can be reduced significantly by 42%. There is a need for monitoring system and the estab­lishment of hospital case mix team in order to optimize the hospital clinical pathway in the JKN era. 

scholarly journals Determining the Cost of Care for U.S. Healthcare Providers: A Hybrid Approach

2020 ◽  
Vol 3 (6) ◽  
Author(s):  
Dr. Mohamed Abualhaija
Keyword(s):  
Unit Cost ◽  
Hybrid Approach ◽  
Healthcare Providers ◽  
Cost Of Care ◽  
Charge Ratio ◽  
Activity Based Costing ◽  
Relative Value ◽  
Efficiency And Effectiveness ◽  
Costing System ◽  
The Cost

Many US healthcare providers can’t easily calculate the cost of treating patients. They use simple calculations such as the cost-to-charge ratio (CCR) which Medicare uses for reimbursement purposes and the ratio-of-cost-to-charge (RCC) which allocates costs to patients based on revenue generated from revenue centers. Healthcare providers are unique, provide different services, and use different resources for treatments. A-one-size-fits-all costing system can’t work for all sizes and different specialty practices. Scholars suggested many costing methods that can be used in different healthcare practices, such as the unit cost analysis, the standard costing method, the gross-costing method, the chart of accounts, the resource-based relative value units (RBRVS), the step-down cost accounting (SDCA), and the activity-based costing (ABC). The purpose of this article is to recommend a costing method that can be easily learned and applied by different size healthcare providers. The proposed hybrid costing approach can help providers calculate the cost of care by capturing the cost of routine and standard exams, treatments, services, and procedures using the process costing system, and capture all other costs that are unique to each patient using the job order costing system. Adequately determining the cost of care will help healthcare leaders improve planning and budgeting for target income and achieve organizational efficiency and effectiveness.

scholarly journals Analysis of Differences between INA CBG’s Rates and Hospital Real Rates in Hemophilia Patients at RSUD Zainoel Abidin Banda Aceh

2020 ◽  
Vol 3 (3) ◽  
pp. 1758-1763
Author(s):  
Sari Haslinur ◽  
Irwan Saputra ◽  
Dedy Syahrizal ◽  
Bakhtiar Bakhtiar ◽  
Said Usman
Keyword(s):  
Local Governments ◽  
Secondary Data ◽  
Health Financing ◽  
P Value ◽  
Hospital Services ◽  
Service Cost ◽  
Significant Difference ◽  
Study Population ◽  
Banda Aceh

INA CBG’s rate is system of health financing packages from government based on cased and hospital services. Real tariff are the actual costs incurred by hospitals service based to local governments. During this time there are differences between INA CBGs rated and hospital rates. Hemophilia is a high-cost disease paid by INA CBGs. The aim of this study was to analyze the differences of INA CBGs and real rates in Hemophilia Patients at RSUDZA Banda Aceh. The research used quantitative analyticmethod. Data collection was carried out by taking secondary data from visits of hemophilia patients at RSUDZA in January-Desember 2019. The study population was all hemophilia patients in RSUDZA in 2019 with purpousive random sample of 100 people. There was a significant difference between INA CBGs rated and hospital rates rates in Hemophilia Patients at RSUDZA Banda Aceh.which indicated by p-value 0,000. Differences between INA CBGs and real rates of hospital are Rp.-431.095.538 or -25%. Differences of INA CBGs rated dan real rates causes’ hospital loss, but hospital needs to re-review the calculation of more efficient service cost to improve the quality of service.

scholarly journals Analysis of the Accuracy of Ina-Cbg's Cost Based on the Type of Disease and Influencing Factors in the Inpatient Installation of RSUD dr. Soegiri Lamongan

2018 ◽  
Vol 2 (1) ◽  
pp. 79-88
Author(s):  
Pujo Broto Iriawan Putra ◽  
Yuly Peristiowati ◽  
Indasah Indasah
Keyword(s):  
Diabetes Mellitus ◽  
Research Design ◽  
Sampling Technique ◽  
Observational Research ◽  
P Value ◽  
Cost Component ◽  
Cross Sectional ◽  
The Real ◽  
Real Cost ◽  
The Cost

The result of monitoring and evaluation of Health Insurance Program (JKN) implementation especially in INA-CBG's claim process at Health Facility of Advanced Rujuan (FKRTL), there are differences of opinion for some cases between FKRTL and BPJS Kesehatan causing delay or problem in payment of claim INA-CBG's. The purpose of this study is to analyze the accuracy of INA-CBG's cost and the factors that influence in RSUD DR. Soegiri Lamongan. This research is a type of observational research with descriptive analytic research design with cross sectional research design according to hospital perspective. The sample in this study amounted to 393 respondents. Sampling technique Simple random sampling technique. The research instrument used using the expense bill file issued and the BPJS patient care claims file file with linear regression statistic test with α = 0.05. The cost component of the biggest Diabetes Mellitus disease is the median cost of Rp. 1.536.346. CVA disease average drug cost Rp. 1.135.399. The biggest DHF disease is the average room cost Rp. 814.067. Appendicitis medicines cost ± Rp. 1.633.961. The incremental cost of INA-CBG's and the actual cost of hospital in Diabetes Mellitus disease is Rp. 357.957, CVA disease difference of Rp. 2.151.170, DHF disease difference of Rp. 477,514 and in appendicitis disease the difference in average minus  -Rp. 2,965,211. There is a difference (not appropriate) between the real cost and the cost of INA-CBG's in Diabetes Mellitus disease with p = 0,000. There is a difference (not appropriate) between the real cost and the cost of INA-CBG's on CVA disease with p value = 0.026. There is a similarity or precision between the real cost and the cost of INA-CBG's in DHF disease with a value of p = 0.159. There is a difference (not appropriate) between the real cost and the cost of INA-CBG's in Apendicitis disease with p = 0,000. There is a difference between the real cost and the cost of INA-CBG's in Diabetes mellitus, CVA, Apendicitis. Factors that affect the differences include room cost factors, drugs and medical action. For DHF disease there is no difference between the real cost and the cost of INA-CBG's.

scholarly journals ANALISIS PERBEDAAN BIAYA RIIL DENGAN TARIF INA-CBG’s DAN FAKTOR YANG MEMPENGARUHINYA UNTUK CHRONIC KIDNEY DISEASE PADA ERA JAMINAN KESEHATAN NASIONAL

2021 ◽  
Vol 1 (1) ◽  
pp. 6-12
Author(s):  
Indriyati Hadi Sulistyaningrum ◽  
Arifin Santoso ◽  
Binarti
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Social Security ◽  
Health Sector ◽  
P Value ◽  
Chi Square ◽  
Cross Sectional ◽  
The Real ◽  
Real Cost ◽  
Real Costs

  Background: The National Social Security System (SJSN) is a system in the health sector that aims to provide comprehensive social security in order to create a just, prosperous and prosperous society. According to WHO growth in the number of Chronic Kidney Disease in 2013 increased by 50% from 2012 even in Southeast Asia to the number of sufferers of Chronic Kidney Disease> 380 million people. While in Indonesia, it has increased by 10% every year. This study aims to determine the differences between INA-CBG rates and the real costs of JKN-era Chronic Kidney Disease patients in RSISA Semarang. Method: This research is an observational study with a retrospective analytic descriptive design with quantitative data. The method used is the Cross Sectional method that makes observations, and can describe the factors that influence the real cost of hospitals. The population was 589 patients with Chronic Kidney Disease and 238 patients and analyzed using the chi-square statistical test with p-value <0.05. Results: The results of the study that as many as 14 patients (5.9%) aged 18-28 years, as many as 50 patients (21.0%) aged 29-39 years, as many as 82 patients (34.5%) aged 40-50 years , as many as 68 patients (28.6%) aged 51-60 years, as many as 21 patients (8.8%) aged 61-70 years as many as 3 patients (1.3%) aged 71-80 years. The research results obtained a p-value of 0,000. Conclusion: There is a Difference between Hospital Real Costs and INA-CBG's Rates for Chronic Kidney Disease in JKN Era in Semarang Hospital in 2018. There are no factors that affect the real costs in chronic kidney disease patients JKN participants in 2018 both class of care, length of treatment (LOS), and disease severity.

Sign in / Sign up

Export Citation Format

Share Document